Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
01 1 » 1 1 (Expand Search), 0 1 (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
1 decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
01 1 » 1 1 (Expand Search), 0 1 (Expand Search)
-
141
-
142
-
143
-
144
-
145
IgG-mediated systemic anaphylaxis decreased in BasoDTR mice.
Published 2013“…<p>(A) BasoDTR mice (n = 4 per group) were treated once i.p. with 25 or 50 µg/kg of DT or PBS at 4 days prior to and were i.v. injected with 500 µg rat anti-FcγRII/III (2.4G2) antibodies in 200 µl PBS. …”
-
146
Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation.
Published 2010“…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”
-
147
-
148
Down-regulation of Gli decreased ovarian cancer cell migration and invasion.
Published 2014“…(<b>B</b>) Expression of both Gli1 and Gli2 mRNA is decreased following treatment with GANT61 (30 µM; 48 hr), determined by real-time PCR. …”
-
149
-
150
-
151
-
152
-
153
Effects of siRNA TMPRSS2-ERG on ERG protein expression and cell viability.
Published 2015“…MTT cell viability assay:</b> VCaP cells were transfected with siRNA TMPRSS2-ERG III (1, 2), TMPRSS2-ERG IV (1) and siRNA Control at 50 nM concentration and incubated for 72h. Bars represent mean ± SD of 2 independent experiments containing 8 replicates for each condition. …”
-
154
Low concentrations of siRNA TMPRSS2-ERG III and IV impair TMPRSS2-ERG oncogene and oncoprotein levels but not cell viability.
Published 2015“…Results are the mean ± SD of two independent experiments containing 8 replicates for each condition. * = <i>p</i><0.05, ** = <i>p</i><0.01, *** = <i>p</i><0.001, significant decrease compared to untreated cells (TA) or to siRNA Control (Kruskal & Wallis followed by Tukey and Dunnet test).…”
-
155
-
156
-
157
-
158
-
159
-
160